Kidney stone disease may be a crystal concretion formed usually within the kidneys. It is an increasing urological disorder of human health, affecting about 12% of the planet population. It has been related to an increased risk of end-stage kidney failure. The ethology of kidney stone is multifactorial. The mechanism of stone formation could also be a posh process which finishes up from several physicochemical events including supersaturation, nucleation, growth, aggregation, and retention of urinary stone constituents within tubular cells. These steps are modulated by an imbalance between factors that promote or inhibit urinary crystallization. It is also noted that cellular injury promotes retention of particles on renal papillary surfaces. The exposure of renal epithelial cells to oxalate causes a signalling cascade which leads to apoptosis by p38 mitogen-activated protein kinase pathways. Currently, there's no satisfactory drug to cure and/or prevent urinary calculus recurrences. Thus, further understanding of the pathophysiology of urinary calculus formation may be a research area to manage urolithiasis using new drugs. Therefore, this review has intended to provide compiled up-to-date information on kidney stone ethology, pathogenesis, and prevention approaches. Kidney stones are mainly lodged in the kidneys. Mankind has been afflicted by urinary stones since centuries dating back to 4000 B.C and it's the foremost common disease of the tract. The prevention of renal stone recurrence remains to be a significant problem in human health. The prevention of stone recurrence requires better understanding of the mechanisms involved in stone formation. Kidney stones are related to an increased risk of chronic kidney diseases, end-stage kidney failure, cardiovascular diseases, diabetes, and hypertension. It has been suggested that urinary calculus could also be a systemic disorder linked to the metabolic syndrome. Nephrolithiasis is liable for 2 to three of end-stage renal cases if it's related to nephrocalcinosis.

The symptoms of urinary calculus are associated with their location whether it's within the kidney, ureter, or bladder. Initially, stone formation doesn't cause any symptom. Later, signs and symptoms of the stone disease contain pain (intense cramping pain), flank pain (pain within the back side), haematuria (bloody urine), obstructive aeropathy (urinary tract disease), urinary tract infections, blockage of urine flow, and hydro nephrosis (dilation of the kidney). These conditions may end in nausea and vomiting with associated affected by the stone event. Thus, the treatment and time lost from work involves substantial cost imposing an impression on the standard of life and nation's economy.

Globally, urinary calculus disease prevalence and recurrence rates are increasing, with limited options of effective drugs. Urolithiasis affects about 12% of the planet population at some stage in their lifetime. It affects all ages, sexes, and races but occurs more frequently in men than in women within the age of 20-49 years. If patients don't apply metaphylaxis, the relapsing rate of secondary stone formations is estimated to be 10–23% per annum, 50% in 5–10 years and 75% in 20 years of the patient. However, lifetime recurrence rate is higher in males, although the incidence of nephrolithiasis is growing among females. Therefore, prophylactic management is of great importance to manage urolithiasis.

Recent studies have reported that the prevalence of urolithiasis has been increasing within the past decades in both developed and developing countries. This growing trend is believed to be related to changes in lifestyle modifications like lack of physical activity and dietary habits and heating. In the US urinary calculus affects 1 in 11 people and it's estimated that 600,000 Americans suffer from urinary stones per annum. In Indian population, about 12% of them are expected to possess urinary stones and out of which 50% may find you with loss of kidney functions.

Journal of Nephrology and Urology is an Open Access peer-reviewed publication that discusses current research and advancements in diagnosis and management of kidney disorders as well as related epidemiology, pathophysiology and molecular genetics.

To submit a new manuscript authors should use the online submission system. Authors may submit their manuscript via online tracking system https://www.imedpub.com/submissions/nephrology-urology.html or as an attachment to email:  nephrolurol@imedpubjournals.com

Regards
Mercy Eleanor
Editorial Assistant
Journal of Nephrology and Urology